Parenteral Nutrition Market Outlook:
Parenteral Nutrition Market size was over USD 8.2 billion in 2025 and is estimated to reach USD 14.7 billion by the end of 2035, expanding at a CAGR of 6.7% during the forecast timeline, i.e., 2026-2035. In 2026, the industry size of the parenteral nutrition is estimated at USD 8.7 billion.
The dominating trends for the international market include the paradigm-based transition to multi-chamber and ready-to-use bags, along with a rise in home parenteral nutrition (HPN). According to an article published by NLM in June 2022, an estimated 25,011 patients receive HPN, along with 437,882 receiving home enteral nutrition, particularly in the U.S. In addition, within a short-term HPN duration, which is almost 6 to 12 weeks, inserting a peripheral central venous catheter is one of the options. Besides, as stated in the August 2025 PIB data report, the government of India surged the utilization modification for gunny bags by almost 40% to ensure seamless operation and support sustainable packaging.
Furthermore, the aspect of advancement in lipid emulsions, along with pharmaconutrition and personalization, is also bolstering the market globally. According to an article published by NLM in February 2024, an estimated 20% of IV lipid emulsion preparations are easily available globally, with the most prevalent formulations constituting 100% long-chain fatty acids readily derived from soybean oil. Besides, other emulsions account for 50% of medium-chain fatty acids, mainly from coconut oil, and the remaining 50% from soybean oil. Meanwhile, the one-size-fits-all concept is increasingly becoming obsolete, with the current focus on personalized formulations, suitable for boosting the market’s exposure.
